Shots: The approval is based on Investigational Device Exemption (IDE) study assessing M6-C artificial cervical disc vs anterior cervical discectomy and fusion (ACDF) in patients with cervical radiculopathy with/out cord compression at between C3 to C7 The US IDE study results @24months: 90.5% improvement in Neck Disability Index; improvement in arm & neck pain score […]Read More
Tags : M6-C
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US